Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Judit Svensson-Arvelund"'
Autor:
Judit Svensson-Arvelund, Sara Cuadrado-Castano, Gvantsa Pantsulaia, Kristy Kim, Mark Aleynick, Linda Hammerich, Ranjan Upadhyay, Michael Yellin, Henry Marsh, Daniel Oreper, Suchit Jhunjhunwala, Christine Moussion, Miriam Merad, Brian D. Brown, Adolfo García-Sastre, Joshua D. Brody
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-18 (2022)
Strategies to advance T cell based immune therapies are mostly focusing on the improvement of CD8 T cell effector functions, such as cytotoxicity or recruitment to the tumor. Here authors show that by combining in situ vaccination with oncolytic Newc
Externí odkaz:
https://doaj.org/article/d4dc7bf6f3c1411dac7c7248c9250073
Autor:
Tejaswi V. Badam, Sandra Hellberg, Ratnesh B. Mehta, Jeannette Lechner-Scott, Rodney A. Lea, Jorg Tost, Xavier Mariette, Judit Svensson-Arvelund, Colm E. Nestor, Mikael Benson, Göran Berg, Maria C. Jenmalm, Mika Gustafsson, Jan Ernerudh
Publikováno v:
Epigenetics, Vol 17, Iss 9, Pp 1040-1055 (2022)
Epigenetics may play a central, yet unexplored, role in the profound changes that the maternal immune system undergoes during pregnancy and could be involved in the pregnancy-induced modulation of several autoimmune diseases. We investigated changes
Externí odkaz:
https://doaj.org/article/82fde3e3be1f4925b203e0997ce02cf5
Autor:
Michael Yellin, Miriam Merad, Henry Marsh, Ranjan Upadhyay, Judit Svensson-Arvelund, Daniel Oreper, Mark Aleynick, Gvantsa Pantsulaia, Kristy Kim, Samuel A Rose, Suchit Jhunjhunwala, Christine Carine Moussion, Brian D Brown, Joshua D Brody
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 7 (2023)
Background Cancer immunotherapies are generally effective in patients whose tumors contain a priori primed T-cells reactive to tumor antigens (TA). One approach to prime TA-reactive T-cells is to administer immunostimulatory molecules, cells, or path
Externí odkaz:
https://doaj.org/article/af511e4b189e4272917485ed9ec6c48a
Autor:
Norah Sadek, Miriam Merad, Brian Brown, Nathalie Scholler, Adrian Bot, Jonathan Boiarsky, Ranjan Upadhyay, Judit Svensson-Arvelund, Aleksandra Wroblewska, Sherry Bhalla, John Rossi, Samir Parekh, Alessia Baccarini
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/8cb372d4946c49d6900c97fc04e36913
Autor:
Joshua D. Brody, Miriam Merad, Brian D. Brown, Judit Svensson-Arvelund, Ranjan Upadhyay, Linda Hammerich, Mark Aleynick, Thomas U. Marron, Keino Hutchinson, Netonia Marshall
Transfer does not induce homeostatic inhibition on CD4+ T-cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::091be4c1b38882232d975b4dd6fb3bad
https://doi.org/10.1158/2159-8290.22536995
https://doi.org/10.1158/2159-8290.22536995
Autor:
Joshua D. Brody, Brian D. Brown, Miriam Merad, Alessia Baccarini, Alessandro Lagana, Samir Parekh, Norah Sadek, John M. Rossi, Adrian Bot, Nathalie Scholler, Sherry Bhalla, Aleksandra Wroblewska, Matthew J. Lin, Judit Svensson-Arvelund, Gvantsa Pantsulaia, Jonathan A. Boiarsky, Ranjan Upadhyay
Supplementary Figures S1-S5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5717e61e5a43e124c9769aa837dffa8b
https://doi.org/10.1158/2159-8290.22536655
https://doi.org/10.1158/2159-8290.22536655
Autor:
Joshua D. Brody, Miriam Merad, Brian D. Brown, Judit Svensson-Arvelund, Ranjan Upadhyay, Linda Hammerich, Mark Aleynick, Thomas U. Marron, Keino Hutchinson, Netonia Marshall
T-cell transfer into lymphodepleted recipients induces homeostatic activation and potentiates antitumor efficacy. In contrast to canonical T-cell receptor–induced activation, homeostatic activation yields a distinct phenotype and memory state whose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a6e73cf6497fd1859089df5ee1e3189
https://doi.org/10.1158/2159-8290.c.6548294.v1
https://doi.org/10.1158/2159-8290.c.6548294.v1
Autor:
Joshua D. Brody, Brian D. Brown, Miriam Merad, Alessia Baccarini, Alessandro Lagana, Samir Parekh, Norah Sadek, John M. Rossi, Adrian Bot, Nathalie Scholler, Sherry Bhalla, Aleksandra Wroblewska, Matthew J. Lin, Judit Svensson-Arvelund, Gvantsa Pantsulaia, Jonathan A. Boiarsky, Ranjan Upadhyay
T cell–based therapies have induced cancer remissions, though most tumors ultimately progress, reflecting inherent or acquired resistance including antigen escape. Better understanding of how T cells eliminate tumors will help decipher resistance m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d49aa3046b7b18a4b4f9c494b28da690
https://doi.org/10.1158/2159-8290.c.6548197.v1
https://doi.org/10.1158/2159-8290.c.6548197.v1
Autor:
Joshua D. Brody, Brian D. Brown, Miriam Merad, Alessia Baccarini, Alessandro Lagana, Samir Parekh, Norah Sadek, John M. Rossi, Adrian Bot, Nathalie Scholler, Sherry Bhalla, Aleksandra Wroblewska, Matthew J. Lin, Judit Svensson-Arvelund, Gvantsa Pantsulaia, Jonathan A. Boiarsky, Ranjan Upadhyay
Supplementary Table S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2977007af1d70e51df9d2c5b7ae2af9d
https://doi.org/10.1158/2159-8290.22536652.v1
https://doi.org/10.1158/2159-8290.22536652.v1
Autor:
Matthew J, Lin, Judit, Svensson-Arvelund, Gabrielle S, Lubitz, Aurélien, Marabelle, Ignacio, Melero, Brian D, Brown, Joshua D, Brody
Publikováno v:
Nature cancer. 3(8)
After several decades, therapeutic cancer vaccines now show signs of efficacy and potential to help patients resistant to other standard-of-care immunotherapies, but they have yet to realize their full potential and expand the oncologic armamentarium
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0998826f6ee151db9a37bd45512b50fe
https://pubmed.ncbi.nlm.nih.gov/35999309
https://pubmed.ncbi.nlm.nih.gov/35999309